NCT04798469

Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism

← Hub

Registry fields

Overall status
RECRUITING
Conditions
Opioid Use, Pain, Hypogonadism, Male
Study type
INTERVENTIONAL
Phase
PHASE2
Primary purpose
TREATMENT
Intervention type
DRUG
Interventions
Testosterone Undecanoate 250 MG/ML, Placebo
Lead sponsor
Brigham and Women's Hospital (OTHER)

Cached at: 2026-07-28 02:39:07

View on ClinicalTrials.gov

Brief summary

The aim of this trial is to evaluate whether testosterone replacement results in greater improvement in pain perception, pain tolerance, sexual function, fatigue, and quality of life when compared with placebo in men with chronic spinal pain treated with opioids who have opioid-induced hypogonadism (low testosterone).

Contact

Need a report or Korean medical writing based on this trial?